24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
@Finance
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
PolyPid
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:42
Zim $4.5 billion bidder faces foreclosure on his home
21:25
NextVision insiders cash out $200 million in share sale
21:14
"If an engineer in Ireland costs 20% less, it is clearly part of the consideration when deciding where to expand"
20:27
Electra Real Estate CEO: “The $7 trillion US rental housing market is the place to be”
More stories
Buzz
Most popular
Daily
Weekly
1
Jewish family from Mexico donates NIS 200 million to establish Israel's largest rehabilitation hospital
2
After raising $20 million, collapsed startup Swish.ai sells to Unframe for just $150,000
3
Echo: “Employees have become very good at identifying performative culture”
4
After PTSD and years of insomnia, Israeli founder raises $6.5 million to improve sleep through scent
5
More than 50 years after its debut, Israel's Kfir fighter jet gets a new lease on life
More news
PolyPid
2 stories about PolyPid
“In the biotech industry, the one thing that is missing more than anything else is funding"
17.10.21
|
CTech
Dikla Czackes Akselbrad, executive vice president and CFO of PolyPid, joins Michael Matias to discuss her bio-pharmaceutical company
Drug Conduction Company Prepares for Nasdaq IPO
08.10.17
|
Golan Hazani
Clinical stage PolyPid develops technology for the predetermined, controlled and localized release of drugs at a targeted site